• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 82 of 100
Sanofi Strikes $2.3 Billion Deal With DiCE Molecules
Health
Sanofi Strikes $2.3 Billion Deal With DiCE Molecules
By ReutersMarch 16, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health
This One Stat Shows Why the Drug Price Issue Won’t Go Away
By Sy MukherjeeMarch 15, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Health
Valeant Just Slashed Its Profit Guidance
By Reuters and Fortune EditorsMarch 15, 2016
Bernie Sanders Holds Super Tuesday Campaign Rally In Vermont
Health
Bernie Sanders Just Proposed a Big Cash Prize to Make AIDS Drugs Cheaper
By Sy MukherjeeMarch 14, 2016
Drip
Health
Why This Bristol-Myers Cancer Drug Is Crushing Its Rivals
By Sy MukherjeeMarch 14, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health
The White House Has Rejected a Controversial Way to Fight High Drug Prices
By Sy MukherjeeMarch 9, 2016
532377729
Health
This Is How Medicare Wants to Lower Your Drug Costs
By Laura LorenzettiMarch 9, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health
Bill Ackman Just Got Himself a Board Member on Valeant
By ReutersMarch 9, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance
Here’s Why Shares of Valeant Are Jumping Today
By ReutersMarch 7, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health
Europe Launches New Fast-Track Scheme for Drug Approval
By ReutersMarch 7, 2016
Scientists Just Made a Major Breakthrough in Personalized Cancer Treatment
Health
Scientists Just Made a Major Breakthrough in Personalized Cancer Treatment
By Sy MukherjeeMarch 4, 2016
Hillary Clinton Holds Post-Super Tuesday Rally In NYC
Finance
This Is Why Hillary Clinton’s Attack on Drug Price Hikes Doesn’t Add Up
By Jen WiecznerMarch 4, 2016
97236087
Health
The FDA Wants to Find Out if Cartoon Drug Ads Are Bad for Consumers
By Sy MukherjeeMarch 2, 2016
The Newly Refurbished Charles Dickens Museum Prepares To Open
Health
Female Viagra Might Not Be All It’s Cracked Up To Be
By Robert HackettMarch 1, 2016
559537925
Health
Why Shares of Diplomat Pharma Got Slammed Today
By Sy MukherjeeMarch 1, 2016
1...
  • 80
  • 81
  • 82
  • 83
  • 84
...100
Most Popular
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Real Estate
The Pentagon and Britain are bracing for the power to go out. The ultrawealthy got there first, with backup generators, escape homes, and stockpilesplaceholder alt text
By Sydney LakeOctober 30, 2026
Politics
Tesla and 113 other companies paid no current federal income tax, but they still aren’t the biggest threats to the federal deficit, think tank warnsplaceholder alt text
By Sasha RogelbergOctober 30, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.